Mitoglitazone ameliorates renal ischemia/reperfusion injury by inhibiting ferroptosis via targeting mitoNEET-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mitoglitazone ameliorates renal ischemia/reperfusion injury by inhibiting ferroptosis via targeting mitoNEET

Published:2023-04 Issue: Volume:465 Page:116440
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Qi Yuanbo,Hu Mingyao,Qiu Yang,Zhang Luyu,Yan Yongchuang,Feng Yi,Feng Chenghao,Hou Xinyue,Wang Zhigang,Zhang Di,Zhao Jie

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference55 articles.

1. Clinical application of kidney biomarkers in cirrhosis;Allegretti;Am. J. Kidney Dis.,2020

2. Ischemia/reperfusion-associated tubular cells injury in renal transplantation: can metabolomics inform about mechanisms and help identify new therapeutic targets?;Barin-Le Guellec;Pharmacol. Res.,2018

3. Organelle-specific regulation of ferroptosis;Chen;Cell Death Differ.,2021

4. Ferroptosis: machinery and regulation;Chen;Autophagy,2021

5. Ferroptosis: a novel therapeutic target for ischemia-reperfusion injury;Chen;Front. Cell Dev. Biol.,2021

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial miR-12294-5p-Regulated Copper Exposure-Caused Mitochondrial-Dependent Ferroptosis by Targeted Inhibition of CISD1 in Chicken Hepatocytes;Journal of Agricultural and Food Chemistry;2024-07-05

2. Metallothionein Alleviates Glutathione Depletion–Induced Oxidative Cardiomyopathy through CISD1-Dependent Regulation of Ferroptosis in Murine Hearts;The American Journal of Pathology;2024-06

3. Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases;Antioxidants;2024-05-27

4. Ferroptosis inhibitors: past, present and future;Frontiers in Pharmacology;2024-05-23

5. Inhibition of CISD1 alleviates mitochondrial dysfunction and ferroptosis in mice with acute lung injury;International Immunopharmacology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3